Portfolio company
Profluent
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops generative artificial intelligence models to design novel proteins and gene editors for pharmaceutical, biotechnology and agricultural organisations.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Profluent Bio
Profluent Bio develops generative artificial intelligence models to design novel functional proteins for biopharmaceutical companies and industrial partners.
310.ai
This company develops generative artificial intelligence models to design novel proteins and biomolecules for pharmaceutical and biotechnology organisations.
Latent Labs
The company develops generative artificial intelligence models to design and optimise proteins for biotechnology and pharmaceutical firms.
Provolut
This company develops artificial intelligence software for protein and enzyme engineering to support researchers in the pharmaceutical and industrial biotechnology sectors.
expressionedits
This company develops a computational platform using artificial intelligence to optimise gene design and enhance protein production for biotechnology and pharmaceutical organisations.
Diffuse Bio
This company develops generative artificial intelligence software and experimental screening platforms for protein design and validation for pharmaceutical and biotechnology researchers.
Generate Biomedicine
This company develops protein-based therapeutics using a generative artificial intelligence platform for pharmaceutical partners and biotechnology firms.
Evozyne
The company creates synthetic therapeutic proteins using generative artificial intelligence for pharmaceutical and biotechnology organisations to treat immune-mediated diseases and genetic disorders.
